Angina Pectoris News and Research

RSS
Sanofi, POZEN ink license agreement to commercialize PA8140 and PA32540 tablets in US

Sanofi, POZEN ink license agreement to commercialize PA8140 and PA32540 tablets in US

Boehringer Ingelheim, Lilly initiate linagliptin clinical trial in adults with Type 2 Diabetes

Boehringer Ingelheim, Lilly initiate linagliptin clinical trial in adults with Type 2 Diabetes

Routine use of FFR at diagnostic coronary angiography changes management in 26% of patients

Routine use of FFR at diagnostic coronary angiography changes management in 26% of patients

Allopurinol may improve CV outcomes in kidney disease

Allopurinol may improve CV outcomes in kidney disease

Intramyocardial injection of organ-derived stem cells after AMI improves left ventricle function

Intramyocardial injection of organ-derived stem cells after AMI improves left ventricle function

Cardiac ischemia plays an important role in adenovector gene transfection in mammalian hearts

Cardiac ischemia plays an important role in adenovector gene transfection in mammalian hearts

Novartis' Arcapta Neohaler now available in the U.S. for COPD treatment

Novartis' Arcapta Neohaler now available in the U.S. for COPD treatment

ICON selected as CRO for Tasly's Dantonic pill global Phase III studies for chronic stable angina pectoris

ICON selected as CRO for Tasly's Dantonic pill global Phase III studies for chronic stable angina pectoris

Combination of prasugrel plus ASA can treat acute coronary syndrome

Combination of prasugrel plus ASA can treat acute coronary syndrome

Ivabradine effective in reducing risk of cardiac fibrosis, diastolic heart failure

Ivabradine effective in reducing risk of cardiac fibrosis, diastolic heart failure

Anesthesia-associated mortality rises again

Anesthesia-associated mortality rises again

Micell initiates enrollment in DESSOLVE II MiStent Drug-Eluting Coronary Stent System trial

Micell initiates enrollment in DESSOLVE II MiStent Drug-Eluting Coronary Stent System trial

Tianyin Pharmaceutical's second quarter revenue increases 69.6% to $25.3 million

Tianyin Pharmaceutical's second quarter revenue increases 69.6% to $25.3 million

Malarial drugs may help treat specific form of frontotemporal dementia

Malarial drugs may help treat specific form of frontotemporal dementia

NovaDel receives $500,000 milestone payment from Akrimax in connection with NitroMist agreement

NovaDel receives $500,000 milestone payment from Akrimax in connection with NitroMist agreement

Micell initiates enrollment in DESSOLVE I clinical trial of MiStent DES

Micell initiates enrollment in DESSOLVE I clinical trial of MiStent DES

J-LANCELOT trial finds E5555 may reduce MACE without increasing serious bleeding events

J-LANCELOT trial finds E5555 may reduce MACE without increasing serious bleeding events

Study examines safety of non-invasive cardiac shock wave procedure for angina pectoris

Study examines safety of non-invasive cardiac shock wave procedure for angina pectoris

Complete revascularization reduces mortality rate in CAD patients

Complete revascularization reduces mortality rate in CAD patients

Study: 28.8% of CAD patients who fails to undergo complete revascularization face higher mortality rate

Study: 28.8% of CAD patients who fails to undergo complete revascularization face higher mortality rate